Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1871142rdf:typepubmed:Citationlld:pubmed
pubmed-article:1871142lifeskim:mentionsumls-concept:C0079281lld:lifeskim
pubmed-article:1871142lifeskim:mentionsumls-concept:C2709248lld:lifeskim
pubmed-article:1871142lifeskim:mentionsumls-concept:C0042396lld:lifeskim
pubmed-article:1871142lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1871142lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:1871142lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:1871142lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1871142lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:1871142lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:1871142pubmed:issue16lld:pubmed
pubmed-article:1871142pubmed:dateCreated1991-9-18lld:pubmed
pubmed-article:1871142pubmed:abstractTextThe 21-amino acid vasoconstrictor peptide endothelin (Et) contains two disulfide bonds. We investigated the importance of the outer disulfide bond in Et-1 by replacing it with an amide linkage. Bioactivity was assessed in an isolated guinea pig lung preparation (perfused at constant flow with Ringer's solution/0.5% albumin) in which pulmonary artery pressure was monitored. Et-1 produced concentration-dependent pulmonary vasoconstriction at concentrations of 1 x 10(-10) M and higher. [Dpr1, Asp15]Et-1 (where Dpr is diaminopropionic acid), in which the outer disulfide was replaced by an amide bond and the inner disulfide was left intact, showed no agonist activity at 1 x 10(-6) M but 1 x 10(-7) M [Dpr1, Asp15]Et-1 inhibited Et-1-induced pulmonary vasoconstriction: effects of 1 x 10(-10) M 2 x 10(-10) M, and 1 x 10(-9) M Et-1 were inhibited by 98%, 75%, and 65%, respectively. Furthermore, this analog did not alter pulmonary vasoconstriction induced by thrombin, norepinephrine, or, most significantly, Et-3. A monocyclic Et-1 analog with the same sequence but in which the amide bond was not formed showed weak pulmonary vasoconstrictor activity (300-500 times less potent than Et-1) but had no antagonist activity. In addition, both the monocyclic control peptide and [Dpr1, Asp15]Et-1 competed effectively with 125I-labeled Et-1 for binding to cultured rat pulmonary artery smooth muscle cells. Thus, an Et-1 structural analog produced by replacement of the outer disulfide bond with an amide linkage displayed potent and specific Et-1 antagonism.lld:pubmed
pubmed-article:1871142pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:languageenglld:pubmed
pubmed-article:1871142pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:citationSubsetIMlld:pubmed
pubmed-article:1871142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1871142pubmed:statusMEDLINElld:pubmed
pubmed-article:1871142pubmed:monthAuglld:pubmed
pubmed-article:1871142pubmed:issn0027-8424lld:pubmed
pubmed-article:1871142pubmed:authorpubmed-author:MalikA BABlld:pubmed
pubmed-article:1871142pubmed:authorpubmed-author:EverittJJlld:pubmed
pubmed-article:1871142pubmed:authorpubmed-author:AndersenT TTTlld:pubmed
pubmed-article:1871142pubmed:authorpubmed-author:SpinellaM JMJlld:pubmed
pubmed-article:1871142pubmed:issnTypePrintlld:pubmed
pubmed-article:1871142pubmed:day15lld:pubmed
pubmed-article:1871142pubmed:volume88lld:pubmed
pubmed-article:1871142pubmed:ownerNLMlld:pubmed
pubmed-article:1871142pubmed:authorsCompleteYlld:pubmed
pubmed-article:1871142pubmed:pagination7443-6lld:pubmed
pubmed-article:1871142pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:meshHeadingpubmed-meshheading:1871142-...lld:pubmed
pubmed-article:1871142pubmed:year1991lld:pubmed
pubmed-article:1871142pubmed:articleTitleDesign and synthesis of a specific endothelin 1 antagonist: effects on pulmonary vasoconstriction.lld:pubmed
pubmed-article:1871142pubmed:affiliationDepartment of Biochemistry and Molecular Biology, Albany Medical College of Union University, NY 12208.lld:pubmed
pubmed-article:1871142pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1871142pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:1871142pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1871142pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1871142lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1871142lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1871142lld:pubmed